Alofer

Quick links to important sections

Alofer

Method of action: Antianemic

Treatment option: Pregnancy

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alofer

Quick Facts

Property Description
Active Ingredients Ferrous Ascorbate, Folic Acid, Zinc
Form Tablet (Film-coated), Syrup, Capsule
Pharmacological Class Haematinic, Nutritional Supplement
General Purpose Support for red blood cell and haemoglobin formation
Origin Synthetic/Derived (Essential nutrients)

What Type of Product is Alofer? (Identity and Classification)

Alofer is defined as an oral combination product classified primarily as a Haematinic and a Nutritional Supplement. A haematinic is a preparation formulated to provide essential nutritional components required for the creation and maturation of healthy blood cells, addressing deficits in minerals and vitamins. Supplementing iron in a bioavailable form is clinically recognized as foundational for managing nutrient deficiencies affecting blood health.

This product is structurally designed to be a convenient, all-in-one product administered via the oral route. It is commonly available in versatile dosage form(s), including tablets (film-coated) and syrup, utilizing synthetic/derived forms of its essential nutrient components for stability and efficient absorption.

What is the Combination of Active Ingredients in Alofer? (Composition and Form)

The definitive composition of Alofer utilizes a synergistic triad of Ferrous Ascorbate, Folic Acid (Vitamin B9), and Zinc. Ferrous Ascorbate serves as a highly effective source of Elemental Iron, valued for its superior absorption profile and intended to replenish the body’s iron stores.

This specialized formula strategically integrates Folic Acid because this essential B vitamin plays a vital role in DNA synthesis and the necessary production of red blood cells. The inclusion of the essential mineral Zinc provides supporting functions for metabolic processes often compromised in deficiency states, completing the comprehensive nutritional support strategy.

What is the General Purpose of a Haematinic Combination? (High-Level Benefit)

The general purpose of the Alofer combination is to provide foundational supportive action for blood health by correcting simultaneous deficits of iron, folate, and zinc. By supplying these essential resources, the preparation assists in sustaining the body’s ability to maintain adequate haemoglobin levels and produce red blood cells.

This supportive action is necessary to ensure the body's capacity for efficient oxygen transport throughout the circulatory system, a function critical for overall energy production and cellular performance. The ultimate benefit focuses on addressing the nutritional causes that impair the production and quality of blood components.

What side effects are possible with Alofer?

Possible side effects and safety information for Alofer

Alofer is a combination product containing Ferrous Ascorbate (an iron source) and Folic Acid (a B-vitamin). The safety profile is largely consistent with the established risks associated with oral iron supplementation and B-vitamin use.

Adverse Reaction Categories and System-Organ Classes

The most commonly reported adverse reactions for oral iron products are primarily related to the Gastrointestinal system. These effects are typically dose-dependent and may include:

  • Common: Nausea, vomiting, abdominal discomfort or stomach upset, constipation, and diarrhea. Iron salts can also cause dark-colored stools.
  • Other Reported: Heartburn.

Folic acid is generally well-tolerated at typical doses. Allergic reactions, while possible, are rare.

Serious and Clinically Significant Adverse Reactions

Acute Iron Toxicity (Overdose): This is a serious, potentially fatal risk, especially in children, and constitutes a medical emergency. Symptoms can rapidly progress and include severe vomiting, diarrhea, abdominal pain, and potential shock.

Hypersensitivity: Rare, but serious allergic reactions (e.g., anaphylaxis) may occur with any component of the formulation.

Population-Specific Safety Considerations

  • Iron Overload: This medication is contraindicated (not to be used) in patients with pre-existing conditions involving iron overload, such as hemochromatosis, as this could worsen the condition.
  • Pediatric Safety: The risk of accidental overdose resulting in poisoning is particularly high in young children. The product must be kept out of reach of children.
  • Pregnancy and Breastfeeding: Use during pregnancy for the treatment or prevention of anemia is generally considered acceptable, but should be managed by a healthcare provider to ensure appropriate dosage.

Safety-Related Restrictions

The absorption of iron can be affected by other substances. The product is subject to regulatory restrictions regarding co-administration with other medicines (including certain antibiotics) and foods that may decrease iron absorption. It is also restricted from use in patients with non-iron-deficiency anemia, as folic acid administration can potentially mask symptoms of Vitamin B12 deficiency.

Overdose and Emergency Response

The official regulatory profile for Alofer overdose focuses on the acute, potentially life-threatening toxicity associated with the elemental iron component (Ferrous Ascorbate). Documented clinical manifestations typically begin within hours with severe gastrointestinal distress, including vomiting, profound abdominal pain, diarrhea, and potential signs of bleeding such as hematemesis or bloody stools.

These corrosive effects may rapidly progress to systemic instability. Severe or life-threatening outcomes described in regulatory documents include the onset of hypovolemic or cardiogenic shock, severe metabolic acidosis, and acute multi-organ failure, primarily affecting the liver and kidneys. Delayed complications, such as gastrointestinal strictures, are also officially documented as a risk for survivors.

Regulatory authorities mandate that any suspected overdose requires immediate medical attention. This warning is critical because the accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Officially described management procedures include intensive symptomatic and supportive treatment, continuous monitoring of vital signs and serial serum iron levels, and the potential use of chelation therapy, which is the documented specific antidote for severe iron toxicity. Hospital observation is required due to the severity and risk of rapid clinical deterioration.

Therapeutic Uses of Alofer

What Alofer Treats: Main Uses and Benefits

Alofer is commonly used in conditions involving nutritional deficiencies commonly linked to anemia caused by essential nutrient deficiencies, a therapeutic domain relevant across periods of heightened physiological stress. This is commonly used in the management of iron deficiency anemia, which often co-exists with folate and zinc deficiency states. Iron supplements are generally used to treat or prevent anemia when dietary intake is insufficient. The preparation helps address symptom clusters that create noticeable physiological strain, particularly pervasive chronic fatigue, substantial physical weakness, and poor concentration that are linked to systemic imbalance.

The product is applied in clinical scenarios marked by significantly increased nutrient requirements, such as during pregnancy and lactation, or during the rapid growth phases of adolescence. It provides support that helps ease the overall symptom burden and assists with maintaining functional stability.


Quick Fact: Relief for Deficiency Symptoms

Alofer is commonly used to manage the chronic fatigue and cognitive symptoms (like mental fogginess) that are characteristic of nutritional anemia. The preparation supports the management of chronic fatigue and cognitive symptoms by addressing the underlying nutritional deficiencies.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Regulatory Restrictions

The eligibility profile for this combination medicine is strictly defined by regulatory authorities based on the components: Ferrous Ascorbate, Folic Acid, and Zinc.

Populations Contraindicated

Use is contraindicated for patients with a known hypersensitivity to any ingredient. It must not be used by individuals with iron overload disorders, including Haemochromatosis or Haemosiderosis. The medicine is also prohibited in cases of Haemolytic Anaemia or any anaemia that is not caused by iron deficiency.

Conditional and Age-Based Eligibility

Age-Related Rules: Use is established for the Adult and Adolescent populations. However, regulatory documents state that safety and effectiveness have not been established for the pediatric population (under 12 years) or the geriatric population (older adults).

Condition-Based Restrictions: The product is improper therapy for Megaloblastic Anaemia caused by Vitamin B12 deficiency, as the folic acid component can mask progressive neurological damage. Use requires explicit caution in patients with Renal Impairment or Hepatic Impairment due to the potential for mineral accumulation. Eligibility during Pregnancy and Lactation is generally established for deficiency treatment/prophylaxis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Alofer, a combination of Iron, Folic Acid, and Zinc, is defined by regulatory documents primarily through pharmacokinetic constraints that affect the plasma concentration of co-administered medicines. The Iron and Zinc components can bind to numerous medicinal products within the digestive system, a pharmacokinetic interaction that substantially reduces the absorption and effectiveness of both the supplement and the co-administered agent.

Exposure-Modifying Interactions

This effect is documented for several classes of oral medicines:

  • Antibiotics: Iron and Zinc reduce the bioavailability of Tetracycline and Quinolone antibiotics. To mitigate this effect, co-administration is subject to mandatory timing rules.
  • Levothyroxine: The iron component interferes with the absorption of the thyroid hormone Levothyroxine.
  • Other Medicines: Iron reduces the absorption of Levodopa, Carbidopa, and Bisphosphonates. Medicines containing Magnesium or Aluminum salts (Antacids) reduce the absorption of Alofer’s iron and folic acid components.

Pharmacodynamic and Timing Constraints

Folic acid has been documented to potentially antagonize the anticonvulsant action of Phenytoin. Additionally, iron is cited as antagonizing the hypotensive action of Methyldopa. To prevent significant pharmacokinetic interactions, mandatory timing rules apply: Antacids must be taken 2 hours before or after Alofer; Levothyroxine must be separated by at least 4 hours; and Tetracycline antibiotics must be separated by 3 to 4 hours. Dietary inhibitors, including milk, tea, and coffee, also reduce iron absorption.

Mechanism of Action

Mechanism of Heme Synthesis Substrate Provision

Alofer provides Iron as a foundational substrate and rate-limiting cofactor necessary for the final steps of heme synthesis. This mechanism directly supports the construction of the hemoglobin molecule, which is required for the binding of oxygen within the erythrocyte. This ensures the availability of the primary structural component for oxygen transport at the systemic level.


Cofactor Activity in DNA Synthesis and Cell Division

The formulation supplies Folic Acid, which functions as a critical coenzyme in the one-carbon metabolism pathway. This pathway is fundamental for the synthesis of purine and pyrimidine bases of DNA and RNA, a molecular cascade utilized for the rapid proliferation and maturation of blood cell precursors in the bone marrow.


Involvement as a Cofactor in Enzyme Systems

The component Zinc operates within a supporting mechanistic domain, functioning as an essential catalytic cofactor for numerous enzymes. This activity supports structural and functional integrity in pathways related to protein synthesis and cellular repair, influencing enzyme systems required for cell proliferation and metabolic processes.

Dosage and Administration Information

The administration of Alofer is strictly via the oral route, utilizing available dosage forms that include tablets (film-coated), capsules, and syrup preparations. The standard regimen for adults typically involves taking one unit (tablet, capsule, or prescribed liquid dose) once daily. However, in certain clinical scenarios, official labeling may specify an adjusted regimen of up to two units per day to achieve the necessary nutrient levels for correction.


Frequency and Contextual Timing

The treatment is a sustained, once daily administration, rather than an intermittent or cyclic schedule. Official instructions present varied guidance regarding the timing of intake in relation to food. To maximize the absorption of the elemental iron component, some labels suggest administering the dose on an empty stomach, approximately one hour before or two hours after meals. Conversely, other regulatory instructions permit the medicine to be taken with a meal to enhance patient comfort and minimize potential gastrointestinal discomfort.


Population Use and Procedural Constraints

Alofer is commonly used as a long-term therapeutic measure to restore depleted body stores of iron and folate, or as a prophylactic measure during periods of increased demand, such as pregnancy. The typical duration of use is sustained over several months until the necessary nutrient balance is achieved. Dosing for pediatric patients is generally required to be specified by a healthcare professional and is scaled according to body weight and age. Solid dosage forms, such as film-coated tablets, are intended to be swallowed whole and should not be crushed or broken.

Recent Clinical Evidence

Alofer: Recent Clinical Evidence


Evidence for use in Chronic Fatigue State

Alofer was evaluated in research involving adults experiencing a chronic fatigue state in small, short-term randomized trials (typically a few weeks). Studies monitored patient-reported outcomes related to fatigue and daily activity level. Findings described patterns observed in these patient populations, but research highlights mixed changes measured during the study period, and evidence is limited due to the trials' scope. Data report patterns related to short-term changes, and certainty remains low. Long-term outcomes are not fully established, and results apply only to the studied populations due to modest sample sizes.


Evidence for use in Mild Cognitive Decline

Alofer was observed in studies involving older adults experiencing mild cognitive changes, which are conditions where symptoms may vary in intensity. Research examined outcomes related to cognitive performance using standardized tests over defined time intervals (usually less than six months). Preliminary evidence describes measured patterns related to cognitive test scores, but the data are still emerging, and comparative evidence is lacking. Research does not determine whether an individual will respond similarly over the course of years.


Evidence for use in General Stress Response

Research examined outcomes monitoring physiological strain or stress where the compound was observed, primarily in healthy volunteers following laboratory-induced stressors. Evidence is focused on acute changes measured during study observations. Research describes short-term patterns related to physiological markers, but these reported outcomes were not always consistent with patient-reported discomfort. Data for chronic stress or mood disorders are insufficient.


Research Limitations and Uncertainties

Certainty remains low for many aspects of Alofer's observed use because follow-up durations were limited and sample sizes were modest. Findings were mixed across different settings, and evidence quality varies across studies. Specifically, there is limited information for long-term outcomes. Furthermore, data for special populations, such as children, pregnant individuals, or those with complex co-morbidities, remain insufficient. Research provides context but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Alofer (FAQ)

Q: Is Alofer used for anything other than its main purpose?

Official documents state that the primary purpose of Alofer is to correct or prevent deficiencies of iron, folic acid, and zinc that are essential for red blood cell formation. The combination is also specifically used as a measure to prevent deficiency during high-demand periods like pregnancy. Additionally, limited research has investigated patterns of use related to chronic fatigue and mild cognitive decline.

Q: Does Alofer make you feel tired or sleepy?

Drowsiness is not listed among the most commonly reported side effects of Alofer in regulatory documents. However, official safety information describes the necessary precaution to avoid driving or operating heavy machinery if side effects such as dizziness or drowsiness are experienced until feeling alert.

Q: How quickly do people typically start to notice the intended effects of Alofer?

The time required to observe the intended effects depends on the severity of the nutritional deficit being addressed. While the general onset of the pharmacological action may begin within a few hours, clinical improvements may take longer. Treatment is typically sustained over several months to fully replenish the body's nutrient stores.

Q: Can Alofer be taken with over-the-counter pain relievers like ibuprofen or acetaminophen?

Official information indicates that the folic acid component is often combined with acetaminophen (paracetamol) in regulatory settings. However, drug-interaction information notes that caution is necessary when co-administering the folic acid component with non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin.

Q: Does Alofer interact with supplements like vitamins or herbal remedies?

Official labeling notes that some components can interact with other substances. For example, official instructions require separation or recommend avoiding co-administration of calcium-rich supplements or dairy products, as they may reduce iron absorption. The folic acid and zinc components can also influence each other's effectiveness.

Q: Are changes in mood or anxiety common side effects of Alofer?

Official adverse event reporting for this combination product does not commonly list changes in mood or anxiety as direct side effects. The product is intended to treat nutrient deficiencies; the resolution of these deficits is the product’s aim.

Q: Is it normal to have a slight headache after starting Alofer?

Headache is not listed among the most commonly reported side effects for adults taking Alofer. The most frequently reported adverse reactions relate to the gastrointestinal system, such as nausea, abdominal discomfort, and constipation.

Q: If I stop taking Alofer, will the condition come back immediately?

Alofer is intended for long-term use, typically sustained over several months, to restore the body's iron and folate stores. If the treatment is discontinued before the underlying nutritional deficiency is fully corrected and maintained, the symptoms associated with the deficiency may eventually return.

Q: Can Alofer be taken before a surgery?

The safety precautions section of the label describes the importance of reporting all medications, including Alofer, to a healthcare professional before undergoing any surgical procedure. This is particularly important for surgeries involving the stomach or intestines.

Q: What is the risk of dependence or addiction with Alofer?

Regulatory documents classify Alofer as a Haematinic and Nutritional Supplement. Based on its composition and pharmacological class, there is no reported risk of dependency or addiction associated with the use of this combination of nutrients.

Q: Is it true that Alofer is used to treat [Common Misconception Disease]?

The regulatory purpose of this combination product is strictly defined. It is intended only to address and prevent nutritional deficiencies of iron, folic acid, and zinc that are essential for red blood cell formation. It is not indicated for treating other, non-deficiency-related conditions.

Q: Can Alofer affect fertility in men or women?

Official manufacturer statements indicate that the supplement is not directly associated with adversely affecting fertility in men or women. However, the essential nutrients within Alofer are known to support general cellular processes, including those related to reproductive function.

Q: What should be done if a dose of Alofer is missed?

The patient information leaflet describes a protocol for managing a missed dose. This protocol typically instructs the user to take the dose when remembered, unless it is near the next scheduled time, and to avoid taking two doses at the same time.

Q: Can Alofer be taken with alcohol?

Official warnings indicate that chronic or excessive consumption of alcohol may increase the elimination of folic acid from the body. This can potentially lead to or worsen a folate deficiency. Official warnings primarily focus on this risk of deficiency.

Q: How does Alofer affect the immune system?

The formulation includes the mineral zinc, which is officially described in the product’s uses as supporting and enhancing immune system function. The zinc component is vital for this supportive action.

Q: What does 'contraindicated' mean in the context of Alofer?

'Contraindicated' refers to a condition or situation where regulatory authorities have determined the drug must not be used. This is because the risk of harm, such as worsening an existing condition like iron overload or causing an allergic reaction, outweighs any potential benefit.

Q: Can women who are planning to become pregnant use Alofer?

Official guidelines acknowledge that folic acid supplementation is often indicated for women who are planning to become pregnant. This use supports healthy fetal development and helps prevent neural tube defects. Use during the pre-conception stage is generally considered acceptable for deficiency treatment or prevention.

Q: Can I drive or operate machinery while taking Alofer?

While the supplement is generally reported to have no direct impact on the ability to drive, the product label includes a necessary precaution to avoid driving or operating heavy machinery if side effects such as dizziness or drowsiness are experienced.

Q: Is Alofer known to cause hair loss?

Hair loss is not listed as a common or serious adverse event of the Alofer supplement in regulatory documents. However, severe iron deficiency anemia, which the supplement is intended to treat, can sometimes be a contributing factor to hair loss.

Q: Why is Alofer only available by prescription?

Alofer is available only by prescription because the specific combination and dosage are intended to treat a diagnosed medical deficiency. Regulatory practice dictates that high-dose iron and folate combinations require professional supervision for proper diagnosis and monitoring.

Q: Does Alofer interfere with laboratory blood tests?

Official regulatory information indicates that the Ascorbic Acid component of the formulation can interfere with some laboratory tests. This interference may potentially cause inaccurate results (false increases or decreases) for certain chemical analytes measured in the blood.

Q: What are the signs of an allergic reaction to Alofer?

Serious allergic reactions (hypersensitivity) are possible but rare. Signs of a severe reaction may include hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. Less severe hypersensitivity symptoms such as rash, itching, and general malaise have also been reported.

Q: Does Alofer interact with common blood pressure medicines?

Regulatory warnings state that the iron component of Alofer can interfere with the absorption of some medications, including certain blood pressure drugs like Methyldopa. Official instructions describe necessary timing separation to mitigate this effect.

How should Alofer be stored and disposed of?

How to Store and Dispose of Alofer?

Official regulatory labeling dictates strict conditions for the storage and disposal of Alofer (Ferrous Ascorbate, Folic Acid, and Zinc) to ensure stability and safety.

Storage Conditions

The product must be stored at a temperature below 30 C (86 F) in a dry place and be protected from light. These conditions support the product's documented shelf life. Alofer must be kept in a tight, light-resistant container, ideally one equipped with a child-resistant closure. Critically, the medicine must be stored out of the sight and reach of children due to the serious risk of accidental iron overdose.

Disposal Instructions

Unused or expired Alofer must not be thrown into household waste or flushed down the toilet. Disposal of all residual or expired product must be performed strictly in accordance with local requirements for pharmaceutical waste handling, as stated in official labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alofer found in:

A-Z Index: